Oral Anticoagulant Use in Patients with Non Valvular Atrial Fibrillation: Analysis of Electronic Medical Record Data

Study identification

• EU PAS number:
  EUPAS17684
• Study ID:
  17685
• Official title and acronym:
  Oral Anticoagulant Use in Patients with Non Valvular Atrial Fibrillation: Analysis of Electronic Medical Record Data
• DARWIN EU® study:
  No
• Study countries:
  United States
• Study description:
  This retrospective cohort study will involve adult NVAF patients treated with an oral anti-coagulant (OAC). Key study outcomes include safety and effectiveness endpoints.
• Study status:
  Planned

Research institutions and networks

Institutions

Boston Health Economics

Study timelines

Date when funding contract was signed

Planned: 01/10/2017

Study start date

Planned: 20/01/2017

Data analysis start date

Planned: 17/02/2017

Date of interim report, if expected

Planned: 28/02/2017

Date of final study report

Planned: 24/03/2017

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Pfizer, Inc.

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable